| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |